thp 1 erap1 ko cells (ATCC)
Structured Review

Thp 1 Erap1 Ko Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 20848 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/thp 1 erap1 ko cells/product/ATCC
Average 99 stars, based on 20848 article reviews
Images
1) Product Images from "ERAP1 Activity Modulates the Immunopeptidome but Also Affects the Proteome, Metabolism, and Stress Responses in Cancer Cells"
Article Title: ERAP1 Activity Modulates the Immunopeptidome but Also Affects the Proteome, Metabolism, and Stress Responses in Cancer Cells
Journal: Molecular & Cellular Proteomics : MCP
doi: 10.1016/j.mcpro.2025.100964
Figure Legend Snippet: Analysis of the immunopeptidome of WT, inhibitor-treated, and ERAP1 KO A375 cells. Panel A , heat map from LC-MS/MS run 1 showcasing peptide distribution across different experimental conditions. Hierarchical clustering was calculated by Manhattan distance. Colors indicate peptide intensities, ranging from low ( red ) to high ( blue ). (Graph generated with Spectronaut v. 19). Panel B , principal component analysis (PCA) from LC-MS/MS run 1. Principal components 1 and 2 contribute to the explanation of 50% of the sample variability. Based on these two PCs, WT samples ( circle ), inhibitor-treated samples ( diamond ), and KO samples ( square ) formed three distinct groups, indicating that the replicates within each group share similarities with each other but there were differences in the immunopeptidomes between different treatments. Panels C – E , volcano plots from LC-MS/MS run 1 indicating the statistical significance of the differences between ( C ) the inhibitor-treated and the WT A375 cells, ( D ) the genetically modified (KO) and the WT A375 cells, and ( E ) the KO versus inhibitor-treated cells. Each circle represents a unique peptide sequence. Peptides with a q-value ≤0.05 and a log2 fold change ≥1 are considered statistically significant. ERAP, endoplasmic reticulum aminopeptidase.
Techniques Used: Liquid Chromatography with Mass Spectroscopy, Generated, Genetically Modified, Sequencing
Figure Legend Snippet: Binding affinity predictions and length distribution of binders. Panel A , distribution of predicted affinities (NetMHCpan-4.1) of the significantly upregulated or downregulated peptides after inhibitor treatment or ERAP1 KO for the HLA alleles present in A375 cells (A∗01:01, A∗02:01, B∗44:03, B∗57:01, C∗06:02, and C∗16:01). Each point on the graph signifies a distinct peptide sequence. Only the score for the top predicted HLA allele is depicted for each peptide. A set of random peptide sequences generated by RandSeq ( https://web.expasy.org/randseq/ ) was also plotted as negative control. Prediction scores below 2 ( dashed line ) indicate binding to at least one of the HLA alleles, with scores below 0.5 ( dotted line ) indicating strong binding. Panel B , length distribution of the significantly upregulated or downregulated binding peptides after inhibitor treatment or ERAP1 KO. ERAP, endoplasmic reticulum aminopeptidase; HLA, human leukocyte antigen.
Techniques Used: Binding Assay, Sequencing, Generated, Negative Control
Figure Legend Snippet: Immunogenicity analysis of A375 cells. Panel A , representative fluorescence microscopy images of activated PBMCs ( red ) and caspase positive cells ( green ) in all conditions. Panel B , graph showing the changes in caspase-positive inhibitor-treated ( diamond ) and ERAP1 KO ( square ) A375 cells, compared to A375 WT cells ( circle ). The average, with its respective SD, was calculated from six images per experimental condition. Statistical significance was evaluated by one-way ANOVA, followed by Dunnett’s multiple comparisons test in GraphPad Prism v.8. Panel C , graph showing the change in mean-specific lysis in inhibitor-treated and ERAP1 KO cells in the PBMC cytotoxicity assay. The average, with its respective SD, was calculated from three technical replicates per experimental condition. The calculated adjusted p values comparing KO cells and inhibitor-treated cells to the WT cells are indicated. Statistical significance was evaluated by one-way ANOVA, followed by Dunnett’s multiple comparisons test in GraphPad Prism v.8. ERAP, endoplasmic reticulum aminopeptidase; PBMC, peripheral blood mononuclear cell.
Techniques Used: Immunopeptidomics, Fluorescence, Microscopy, Lysis, Cytotoxicity Assay
Figure Legend Snippet: Proteomic analysis of WT, inhibitor-treated, and ERAP1 KO A375 cells. Panel A , heat map showing the cluster analysis and distribution of proteins in the three conditions (WT, inhibitor-treated, and ERAP1 KO A375 cells) for each replicate (four biological replicates, each measured in three technical replicates) (graph generated with Perseus v. 1.6.15). Panel B , principal component analysis (PCA) of the three experimental conditions. Each point represents a distinct biological or technical replicate. Panels C and D , Hawaii plots of identified proteins, indicating the statistical significance of the observed differences in protein abundance between the two treatment conditions (inhibitor-treated and ERAP1 KO) and the WT cells. Three hundred twenty-five proteins in the inhibitor-treated ( C ) and 1095 proteins in the KO cells ( D ) were differentially expressed. Select proteins that participate in antigen presentation are indicated in red (graph generated with Perseus v. 1.6.15). Panels E , F , and G , heat maps of proteins participating in protein folding ( E ), proteasomal protein catabolic process ( F ), and protein processing in the endoplasmic reticulum ( G ) (graphs generated with Perseus v. 1.6.15). ERAP, endoplasmic reticulum aminopeptidase.
Techniques Used: Generated, Quantitative Proteomics, Immunopeptidomics
Figure Legend Snippet: Dichloro fluorescein assay for measurement of reactive oxygen species. Panel A , representative images of WT, inhibitor-treated (INH), and ERAP1 KO A375 cells incubated with H2DCFDA ( left ) or Hoechst 33342 ( right ). Panel B , total fluorescence intensity per number of nuclei quantitated by direct cell imaging on a Cytation-5 instrument for the three biological conditions. Panel C , relative DCF fluorescence units (RFU) normalized to Hoechst dye fluorescence measured by direct fluorescence measurement on a BioTek Synergy H1 plate reader. The calculated adjusted p values comparing KO cells and inhibitor-treated cells to the WT cells are indicated. Statistical significance was evaluated by one-way ANOVA, followed by Dunnett’s multiple comparisons test in GraphPad Prism v.8. ERAP, endoplasmic reticulum aminopeptidase.
Techniques Used: Incubation, Fluorescence, Imaging
Figure Legend Snippet: Thioflavin T assay for ER stress. Panel A , representative images of WT, inhibitor-treated (INH), and ERAP1 KO A375 cells incubated with thioflavin T with or without treatment with DTT, as described in the Experimental procedures section. Panel B , total fluorescence intensity normalized for cell area for the three biological conditions in the absence or presence of DTT. Statistical significance was evaluated by one-way ANOVA, followed by Dunnett’s multiple comparisons test in GraphPad Prism v.8. ER, endoplasmic reticulum; ERAP, endoplasmic reticulum aminopeptidase.
Techniques Used: ThT Assay, Incubation, Fluorescence
Figure Legend Snippet: Mitotracker assay for measurement of mitochondrial membrane potential. Panel A , representative fluorescence microscopy images of A375 cells (WT, inhibitor-treated, or ERAP1 KO) visualized after staining with DAPI ( blue ) and Mitotracker ( red ) as well as merged. Panel B , total fluorescence intensity of Mitotracker per identified nuclei for the three conditions. The calculated adjusted p values comparing KO cells and inhibitor-treated cells to the WT cells are indicated. Statistical significance was evaluated by one-way ANOVA, followed by Dunnett’s multiple comparisons test in GraphPad Prism v.8. ERAP, endoplasmic reticulum aminopeptidase.
Techniques Used: Membrane, Fluorescence, Microscopy, Staining
Figure Legend Snippet: Seahorse extracellular flux analysis of effects of ERAP1 disruption on cellular metabolism. Panel A , Oxygen Consumption Rate (OCR) followed as a function of time during the experiment for WT, inhibitor-treated and ERAP1 KO A375 cells. Arrows at specific time points indicate the addition of glucose, oligomycin, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) and rotenone/antimycin A to probe different metabolic components, as indicated by the colored regions in the figure. Panels B – G , quantification and comparison of components of mitochondrial metabolism between the three experimental conditions. Panel H , extracellular Acidification Rate (ECAR) followed as a function of time as in panel A. Panels I – L , quantification and comparison of basal glycolytic levels, spare glycolytic capacity, maximum glycolytic capacity and non-glycolytic acidification as calculated form the ECAR measurements. Statistical significance was evaluated by one-way ANOVA, followed by Dunnett’s multiple comparisons test in GraphPad Prism v.8.
Techniques Used: Disruption, Comparison